Literature DB >> 7103279

Bronchoalveolar lavage in a patient with chronic berylliosis: evidence for hypersensitivity pneumonitis.

P E Epstein, J H Dauber, M D Rossman, R P Daniele.   

Abstract

Because immunologic mechanisms are thought to have a role in chronic berylliosis, we studied the immunologic properties of peripheral blood and bronchoalveolar lymphocytes in a patient with this disease. Although the percent of peripheral blood T cells was slightly reduced compared with that in controls (59% versus 70%), there was a large increase in the number and proportion (94% versus 62%) of bronchoalveolar T cells. The percent of activated bronchoalveolar T cells was nearly five times the control value (64.5% versus 14%). Both peripheral blood and bronchoalveolar lymphocytes proliferated in response to BeSO4 and BeF2 exposure but the response of bronchoalveolar lymphocytes was greater than comparable numbers of peripheral blood lymphocytes. These findings are consistent with the concept that chronic berylliosis is a form of hypersensitivity pneumonitis and that bronchoalveolar lavage may be helpful in establishing the diagnosis of this disease.

Entities:  

Mesh:

Year:  1982        PMID: 7103279     DOI: 10.7326/0003-4819-97-2-213

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

Review 1.  Clinical application of beryllium lymphocyte proliferation testing.

Authors:  Barbara P Barna; Daniel A Culver; Belinda Yen-Lieberman; Raed A Dweik; Mary Jane Thomassen
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

2.  Scintigraphy with J001X, a Klebsiella membrane glycolipid, for the early diagnosis of chronic berylliosis: results from an experimental model.

Authors:  P Diot; A Le Pape; D Nolibe; G Normier; H Binz; J P Revillard; G Lasfargues; M Lavandier; E Lemarié
Journal:  Br J Ind Med       Date:  1992-05

3.  Screening for chronic beryllium disease using beryllium specific lymphocyte proliferation testing.

Authors:  T N Markham
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

4.  Bronchoalveolar lavage.

Authors:  J Golden
Journal:  West J Med       Date:  1986-09

5.  Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease.

Authors:  Andrew P Fontenot; Scott J Canavera; Laia Gharavi; Lee S Newman; Brian L Kotzin
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

6.  Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subset.

Authors:  C Saltini; J R Spurzem; J J Lee; P Pinkston; R G Crystal
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

7.  Bias toward use of a specific T cell receptor beta-chain variable region in a subgroup of individuals with sarcoidosis.

Authors:  D R Moller; K Konishi; M Kirby; B Balbi; R G Crystal
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

Review 8.  The inorganic dust pneumoconioses.

Authors:  R P Stankus; J E Salvaggio
Journal:  Clin Rev Allergy       Date:  1985-05

Review 9.  The natural history of beryllium sensitization and chronic beryllium disease.

Authors:  L S Newman; J Lloyd; E Daniloff
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

Review 10.  Chronic beryllium disease: diagnosis and management.

Authors:  M D Rossman
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.